The North American market for insulin pumps is expanding at a large rate due to the population's fast increasing prevalence of diabetes and growing understanding of how to treat it. The International Diabetes Federation (IDF) estimates that there were 537 million people with diabetes worldwide in 2021, and that figure is expected to climb to 783 million by the year 2045. According to the World Health Organization, diabetes can result in blindness, renal failure, and stroke. The North American insulin pump market is expanding at a large rate due to factors such as rising healthcare costs, easier access to healthcare facilities, and the widespread availability of upgraded insulin pumps. The demand for insulin pumps is increasing as a result of the rising requirement for routinely regulating blood glucose levels. The technological developments in drug delivery systems are also providing a wealth of opportunities for market players to flourish.